<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: The Reaper&#8217;s Guide to Short Selling Stocks</title>
	<atom:link href="http://www.goodevalue.com/2007/11/15/the-reapers-guide-to-short-selling-stocks/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.goodevalue.com/2007/11/15/the-reapers-guide-to-short-selling-stocks/</link>
	<description>It may be cheap, but is it a Goode value?</description>
	<lastBuildDate>Wed, 03 Mar 2010 20:08:02 -0500</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Goode Value Investing Blog &#187; Update on my stock picks and pans</title>
		<link>http://www.goodevalue.com/2007/11/15/the-reapers-guide-to-short-selling-stocks/comment-page-1/#comment-280</link>
		<dc:creator>Goode Value Investing Blog &#187; Update on my stock picks and pans</dc:creator>
		<pubDate>Tue, 29 Jan 2008 19:58:05 +0000</pubDate>
		<guid isPermaLink="false">http://www.goodevalue.com/2007/11/15/the-reapers-guide-to-short-selling-stocks/#comment-280</guid>
		<description>[...] Noble Roman&#8217;s (OTC BB: NROM), or Octillion (OTC BB: OCTL). After having almost doubled since I wrote about it, Cellcyte has now fallen 90%. Noble Roman&#8217;s is down over 40% since I first wrote about it. [...]</description>
		<content:encoded><![CDATA[<p>[...] Noble Roman&#8217;s (OTC BB: NROM), or Octillion (OTC BB: OCTL). After having almost doubled since I wrote about it, Cellcyte has now fallen 90%. Noble Roman&#8217;s is down over 40% since I first wrote about it. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.348 seconds -->
